Midostaurin in MRD (Minimal Residual Disease) Positive Acute Myeloid Leukemia After Allogeneic Stem Cell Transplantation
Clinical trial NCT03951961 · TERMINATED
Trial details
- NCT number
- NCT03951961
- Sponsor
- University of Jena
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-20
- Primary completion
- 2021-02-28
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.